[Sertraline-induced chronic eosinophilic pneumonia].
Pneumopathie chronique à éosinophiles induite par la sertraline.
Depression
Drug-induced lung disease
Dépression
Inhibiteurs de la recapture de la sérotonine
Pneumonie à éosinophiles
Pneumopathie médicamenteuse
Pulmonary eosinophilia
Serotonin reuptake inhibitors
Sertraline
Journal
Revue des maladies respiratoires
ISSN: 1776-2588
Titre abrégé: Rev Mal Respir
Pays: France
ID NLM: 8408032
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
10
05
2020
accepted:
05
10
2020
pubmed:
15
2
2021
medline:
31
8
2021
entrez:
14
2
2021
Statut:
ppublish
Résumé
Sertraline is a selective serotonin reuptake inhibitor which is often used as first-line treatment for depression. Several patterns of interstitial lung disease attributable to sertraline have been reported in the literature. A 69-year-old patient, who had been taking sertraline to treat severe depression for 10 months, presented with a deterioration in his general condition and respiratory symptoms found to be associated with bilateral pneumonitis. An exhaustive assessment did not reveal any infectious or autoimmune aetiology. Transthoracic lung biopsy revealed a pattern of eosinophilic lung disease. Sertraline-induced lung toxicity was then suspected and this treatment was therefore stopped. The patient's symptoms resolved and the chest imaging normalized. Our observation suggests that sertraline was the cause of chronic eosinophilic pneumonia characterized by an insidious clinical presentation several months after starting the medication. Given its widespread prescription, we encourage any clinician facing this disease to pay attention to possible drug-induced origins of lung disease.
Identifiants
pubmed: 33581985
pii: S0761-8425(20)30378-8
doi: 10.1016/j.rmr.2020.11.012
pii:
doi:
Substances chimiques
Serotonin Uptake Inhibitors
0
Sertraline
QUC7NX6WMB
Types de publication
Case Reports
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
210-214Informations de copyright
Copyright © 2020 SPLF. Published by Elsevier Masson SAS. All rights reserved.